Vaxcyte, Inc.
Vaxcyte, Inc. (PCVX) Stock Overview
Explore Vaxcyte, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4.7B
P/E Ratio
-9.82
EPS (TTM)
$-3.99
ROE
-0.17%
PCVX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Vaxcyte, Inc. (PCVX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 58.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $125.83.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.82 and a market capitalization of 4.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.